Purdue Pharma

Purdue pleaded guilty to an information charging it with three felony offenses: one count of dual-object conspiracy to defraud the United States and to violate the Food, Drug, and Cosmetic Act, and two counts of conspiracy to violate the Federal Anti-Kickback Statute.

Purdue admitted that from May 2007 through at least March 2017, it conspired to defraud the United States by impeding the lawful function of the Drug Enforcement Administration (DEA).

Purdue made payments to Practice Fusion Inc., an electronic health records company

including a criminal fine of $3.544 billion and an additional $2 billion in criminal forfeiture.

Purdue has also agreed to a civil settlement that provides the United States with an allowed, unsubordinated, general unsecured bankruptcy claim for recovery of $2.8 billion to resolve its civil liability under the False Claims Act.

the claims resolved by the civil settlements are allegations only. There has been no determination of liability in the civil matters.

In 1999, Richard Sackler became the CEO of Purdue.

Jonathan, Kathe, and Mortimer were Vice Presidents.

At the OxyContin launch party, Richard Sackler spoke as the Senior Vice President responsible for sales.

PURDUE PHARMA L.P., PURDUE PHARMA INC., RICHARD SACKLER, THERESA SACKLER, KATHE SACKLER, JONATHAN SACKLER, MORTIMER D.A. SACKLER, BEVERLY SACKLER, DAVID SACKLER

My son was only 28 years old when he died from Oxycontin on New Year’s Day. We all miss him very much, his wife especially on Valentines’ Day.

Craig Landau, President and CEO, Purdue Pharma L.P.

I joined the Purdue board of directors in 2012 and served as the director until 2018.

Dr. Kathe Sackler, Former Vice President and Member of the Board of Directors, Purdue Pharma L.P.

Within two years, he had taken a job at Purdue.

Violations Prove Costly to Maker of OxyContin

In May 2013, Purdue retained McKinsey to conduct a rapid assessment of the underlying drivers of OxyContin performance

Respondent Purdue Pharma sits at the center of that crisis.

Purdue sits at the center of these events.

In 2019, Purdue filed for Chapter 11 bankruptcy.

Between 2008 and 2016, the family’s distributions totaled approximately $11 billion, draining Purdue’s total assets by 75% and leaving it in “a significantly weakened financial” state.

After the plea agreement, the Sacklers began taking as much as 70% of the company’s revenue each year.

Despite this finding, Purdue’s supervisors and employees falsely and misleadingly marketed OxyContin as less addictive, less subject to abuse, and less likely to cause withdrawal than other pain medications.

Purdue Pharma has been dissolved following the conclusion of its bankruptcy case, putting into effect a $7.4 billion national opioid settlement